MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0026251
Saprac Pharmaceutical Private Limited
Saprac Pharmaceutical Private Limited - pharma in Delhi, India. Directors, charges & compliance details.
Revenue · FY 2024
₹13.37 Lakh
Latest filing
Net profit · FY 2024
₹17,417
Net margin 1.3%
EBITDA · FY 2024
₹31,928
EBITDA margin 2.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date
About Saprac Pharmaceutical Private Limited
Data last updated:
Saprac Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 19 July 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2022PTC401958.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Santosh Kumar and Sweta Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. – 17 S/F Khata No31/24/17/14/&25 Harijan Basti Sector – 7 Dwarka, Delhi, India – 110045.
As per the financials filed for FY 2024, the company reported a revenue of ₹13.37 Lakh. For the same year it recorded a net profit of ₹17,417 (net margin 1.3%) and EBITDA of ₹31,928 (EBITDA margin 2.4%).
Saprac Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0026251).
Company details
CIN U24230DL2022PTC401958
Registration Number 401958
Incorporation Date 19 July 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0026251
Recognitions & Rankings of Saprac Pharmaceutical
Contact details
Saprac Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered AddressPlot No. – 17 S/F Khata No31/24/17/14/&25 Harijan Basti Sector – 7 Dwarka, Delhi, India – 110045
- IndustryPharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Saprac Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Saprac Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Saprac Pharmaceutical Private Limited, buy the company report.
Financials of Saprac Pharmaceutical Private Limited
FY 2025 filings availableSaprac Pharmaceutical Private Limited reported revenue of ₹13.37 Lakh for FY 2024.
Revenue · FY 2024
₹13.37 Lakh
Net profit · FY 2024
₹17,417 margin 1.3%
EBITDA · FY 2024
₹31,928 margin 2.4%
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹31,928 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹17,417 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 2.4% | |
| Net Profit Margin | 1.3% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Saprac Pharmaceutical Private Limited, buy the company report.
Board of directors of Saprac Pharmaceutical Private Limited
Saprac Pharmaceutical has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Kumar | Director | 12 Mar 2024 | 2 Years 8 Months | Current |
| Sweta Kumari | Director | 12 Mar 2024 | 2 Years 8 Months | Current |
| Rupa Kumari | Director | 19 Jul 2022 | 4 Years 3 Months | Current |
| Rashmi Kumari | Director | 19 Jul 2022 | 4 Years 3 Months | Current |
Peer comparison
Saprac Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wanya Lifesciences Private Limited | ₹13.4 Lakh (FY 2024) | Hubli, Karnataka, India | ||||
| Thirumoolar International Siddha Medical Research Foundation | ₹13.39 Lakh (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Arobel International (OPC) Private Limited | ₹13.39 Lakh (FY 2025) | -58.0% | Chavakkad, Kerala, India | |||
| Enlocare Chemicals Private Limited | ₹13.39 Lakh (FY 2025) | 1.0% | Kasargod, Kerala, India | |||
| Augment Pharmaceutical Private Limited | ₹13.38 Lakh (FY 2024) | 2.0% | Japiur, Rajasthan, India | |||
| Saprac Pharmaceutical Private Limitedthis company | ₹13.37 Lakh (FY 2024) | ₹17,417 | 1.3% | Delhi, India | ||
| Sanmedicare Pharma Private Limited | ₹13.36 Lakh (FY 2019) | 39.0% | Gorakhpur, Uttar Pradesh, India | |||
| Satvah Surfactants Private Limited | ₹13.36 Lakh (FY 2024) | -84.0% | Ahmedabad, Gujarat, India | |||
| Westmid Industries Private Limited | ₹13.35 Lakh (FY 2025) | Belda, West Bengal, India | ||||
| Venuschem Laboratories Private Limited | ₹13.34 Lakh (FY 2024) | 440.0% | Navi Mumbai, Maharashtra, India | |||
| Thampuratty's India Private Limited | ₹13.33 Lakh (FY 2022) | 262.0% | New Delhi, Delhi, India |
To see the full peer comparison of Saprac Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saprac Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saprac Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Saprac Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Saprac Pharmaceutical Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Santosh Kumar was appointed as Director on 12 Mar 2024.
AGM
Saprac Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Saprac Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Appointed
Santosh Kumar was appointed as Director.
Appointed
Sweta Kumari was appointed as Director.
Appointed
Rashmi Kumari was appointed as Director.
Appointed
Rupa Kumari was appointed as Director.
Incorporation
19 Jul 2022
Saprac Pharmaceutical Private Limited was registered on 19 Jul 2022 with Roc Delhi I & aged 4 years 3 months as per MCA records.
Frequently asked questions
Saprac Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 19 July 2022 (4+ years old) and is registered under CIN U24230DL2022PTC401958.
Saprac Pharmaceutical has 4 current directors:
- Santosh Kumar - Director
- Sweta Kumari - Director
- Rupa Kumari - Director
- Rashmi Kumari - Director
The latest financial statements of Saprac Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Saprac Pharmaceutical is U24230DL2022PTC401958. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saprac Pharmaceutical was incorporated on 19 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Saprac Pharmaceutical by revenue are Wanya Lifesciences Private Limited, Thirumoolar International Siddha Medical Research Foundation, Arobel International (OPC) Private Limited, Enlocare Chemicals Private Limited, Augment Pharmaceutical Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Santosh Kumar was appointed as Director on 12 Mar 2024. Sweta Kumari was appointed as Director on 12 Mar 2024. Rashmi Kumari was appointed as Director on 19 Jul 2022. Saprac Pharmaceutical has 4 board changes on record in total.
Yes, Saprac Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0026251).
The registered office of Saprac Pharmaceutical is at Plot No. – 17 SF Khata No31241714&25 Harijan Basti Sector – 7 Dwarka, Delhi, India – 110045.
Saprac Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Saprac Pharmaceutical can be reached at its registered office: Plot No. – 17 SF Khata No31241714&25 Harijan Basti Sector – 7 Dwarka, Delhi, India – 110045.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages